跳转至内容
Merck
CN
  • In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

Journal of thrombosis and haemostasis : JTH (2007-03-29)
G T Gerotziafas, I Elalamy, F Depasse, E Perzborn, M M Samama
材料
产品编号
品牌
产品描述

Sigma-Aldrich
Rivaroxaban, ≥98% (HPLC)